Search - tctmd.com

Displaying 21 - 40 of 177

Sort: Relevancy | Date

News Conference News STS 2024

Multiarterial Grafting in CABG Triumphs Again in Large Database Study

Yael L. Maxwell

January 29, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

Todd Neale

November 22, 2023

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

News Daily News

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Yael L. Maxwell

October 09, 2023

News Conference News ESC 2023

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

Caitlin E. Cox

August 26, 2023

News Daily News

Surgeons Say ACC/AHA Chronic Coronary Disease Guidelines Whiffed

Michael O'Riordan

August 03, 2023

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

News Industry News

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

June 01, 2023

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

News Daily News

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Michael O'Riordan

February 24, 2023

News Daily News

Interventional Cardiology Training Needs Defined for the First Time

Yael L. Maxwell

February 20, 2023

News Conference News STS 2023

Surgeons Argue: STS Data Again Show ISCHEMIA Isn’t Definitive for CABG

Yael L. Maxwell

January 30, 2023

News Daily News

Top Endovascular News of 2022

L.A. McKeown

January 03, 2023

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News EACTS 2022

Adjunctive Radial Artery Grafts No Better Than SVGs in Multivessel CABG

Michael O'Riordan

October 12, 2022

News Daily News

NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival

Caitlin E. Cox

October 03, 2022

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

Presentation TCT 2022

Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

Presenter: Christos Rammos

September 17, 2022

Advertisement

Multiarterial Grafting in CABG Triumphs Again in Large Database Study

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

Surgeons Say ACC/AHA Chronic Coronary Disease Guidelines Whiffed

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Interventional Cardiology Training Needs Defined for the First Time

Surgeons Argue: STS Data Again Show ISCHEMIA Isn’t Definitive for CABG

Top Endovascular News of 2022

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Adjunctive Radial Artery Grafts No Better Than SVGs in Multivessel CABG

NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content